Participating Faculty

Supplements and Featured Publications, Evaluating Real-world Clinical and Economic Outcomes in the Management of Enlarged Prostate - A New , Volume 13, Issue 1 Suppl

The American Journal of

Managed Care

This supplement to contains information on benign prostatic hyperplasia, its available treatment, and clinical and economic implications of the disease. This supplement has been peer reviewed by experts in the field.


LaKeasha R. Batiste, MS




Senior Director

Palm Harbor, FL

Thomas C. Fenter, MD

University of Mississippi

Blue Cross & Blue Shield of Mississippi

Vice President

Palm Harbor, FL

Muta M. Issa, MD, MBA

Emory University School of Medicine

Medical Center

Professor of Urology


Baltimore, MD

Timothy S. Regan, BPharm, RPh, CPh


Manager, USP Health Outcomes

Research Triangle Park, NC

Manan B. Shah, PharmD, PhD


Faculty Disclosures

These participants report relationships with the following pharmaceutical companies:

  • LaKeasha R. Batiste, MS Research support: GlaxoSmithKline

Libby Black, PharmD


  • GlaxoSmithKline
  • Michael Eaddy, PharmD, PhD Research support: GlaxoSmithKline

Thomas C. Fenter, MD

Lecture support from:

  • GlaxoSmithKline
  • Amy L. Grogg, PharmD Research support: GlaxoSmithKline

Consultant/advisory board/honorarium:

  • GlaxoSmithKline Johnson & Johnson

Consultant/advisory board, honoraria, and lecture support from:

  • Boehringer-Ingelheim
  • Sanofi Aventis
  • Timothy S. Regan, BPharm, RPh, CPh Research support: GlaxoSmithKline

M. Chris Runken, PharmD


  • GlaxoSmithKline
  • Manan B. Shah, PharmD, PhD Research support: GlaxoSmithKline

The American

Journal of Managed Care

It is the policy of to have all faculty who participate in programs sponsored by pharmaceutical companies disclose any real or apparent conflicts of interest.

GlaxoSmithKline provided funding to Xcenda to perform research and development related to this supplement. The authors listed here are employed by Xcenda, which receives grant support from GlaxoSmithKline and other pharmaceutical companies.

The American Journal of

Managed Care

Signed disclosures are on file at the office of , Princeton, New Jersey.


This supplement has been supported by funding from GlaxoSmithKline.


The contents of this supplement may include information regarding the use of products that may be inconsistent outside the approved labeling for these products in the United States. Physicians should note that the use of these products outside current approved labeling is considered experimental and are advised to consult prescribing information for these products.